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Forty-five year follow-up after uninephrectomy. This study examined
the consequences of nephrectomy in United States Army personnel
who lost a kidney due to trauma during World War II (WWII). Records
of 62 servicemen who underwent nephrectomy at an average age of 25
years were obtained. Mortality was compared with that of WWH
servicemen of the same age. Medical records of 28 deceased subjects
were reviewed for evidence of kidney disease. Medical histories were
obtained and blood pressure and kidney function were assessed in 28
living subjects. Two subjects could not be located, and four subjects
declined to participate. Mortality at 45 years was not increased in
nephrectomized subjects. Kidney disease present in six of 28 deceased
subjects was attributable to causes other than prior nephrectomy.
Glomerular sclerosis was not increased in 10 subjects who had autopsy
examinations. The prevalence of hypertension was not increased in
living subjects. Five of 28 living subjects had abnormal renal function
manifested by proteinuria greater than 250 mg/day in four cases (range:
377 to 535 mg/day) and serum creatinine levels greater than 1.5 mg/dl in
three cases (range: 1.7 to 1.9 mg/dl). Conditions other than nephrec-
tomy could have contributed to impairment of renal function in each of
these subjects. These findings suggest that uninephrectomy in young
adults has few major adverse consequences over 45 years.
Renal transplantation has become the preferred therapy for
many people with end-stage renal disease. Currently, graft
survival rates are better when kidneys are obtained from
living-related donors than when kidneys are obtained from
cadavers. Moreover, the supply of cadaveric kidneys is inade-
quate to meet the demand for transplantation. Use of kidneys
from living donors, including nonrelated donors, may thus in
some cases be desirable even when it provides no better graft
survival than use of cadaveric kidneys [1, 2].
Increased use of living donors requires proof that uninephre-
etomy does not have adverse consequences in humans. Labo-
ratory studies have raised concern that reduction in renal mass
can ultimately cause failure of the remnant kidney [3]. Early
studies showed that removal of the majority of the renal mass
caused progressive sclerosis of remnant glomeruli in rats. A
recent study has demonstrated similar glomerular injury follow-
ing partial removal of a solitary kidney in humans [4]. Both
laboratory and clinical studies suggest, however, that unine-
phrectomy is safer than removal of the majority of the renal
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mass. Rats subjected to uninephrectomy develop glomerulo-
sclerosis much less rapidly than rats subjected to more exten-
sive renal ablation [3]. Studies of transplant donors have shown
that uninephrectomy in humans has few, if any, adverse con-
sequences over ten to twenty years [5—i 1]. While these results
are encouraging, longer follow-up of uninephrectomized sub-
jects is necessary to provide complete reassurance to those
contemplating kidney donation early in adult life. Because
transplantation is a relatively new procedure, prolonged fol-
low-up studies cannot be performed in transplant donors. We
therefore examined the consequences of uninephrectomy in 62
United States Army personnel who lost a kidney due to trauma
during World War II (WWII).
Methods
Records for US Army field hospital admissions during WWII
have been maintained by the Medical Follow-Up Agency of the
National Research Council (Washington, D.C.). A computer
search of diagnoses recorded during these admissions identified
495 Army enlisted personnel as having undergone uninephrec-
tomy in field hospitals between 1942 and 1945. Of these 495
personnel, 473 were found to have files in the Veterans Admin-
istration (VA) Beneficiary Identification and Records Locator
Subsystem (BIRLS), The BIRLS files of 163 personnel were
obtained for the current study. Mortality as of June 1988 was
43.2% for the personnel whose files were obtained and 43.6%
for the 473 personnel who had files in BIRLS. The personnel
whose files were obtained were thus considered to be represen-
tative of the whole group subjected to nephrectomy, even
though files were not obtained by a strictly randomized proto-
col.
Personnel whose BIRLS files were obtained were entered
into the study if they met the following criteria: nephrectomy
was performed for trauma; there was no prior history of
hypertension or renal disease; and there were no additional
injuries which would predispose to renal disease. Of the 163
files obtained, 25 were excluded because they did not contain an
adequate description of the wartime injury. The remaining 138
files contained Army field hospital records and, in most cases,
records of post-war disability examinations. The files also
contained VA medical records of personnel who had been cared
for in the VA system. A total of 76 of the 138 personnel whose
files contained adequate information were excluded from the
study. Four personnel were excluded because review of their
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records revealed that nephrectomy had not in fact been per-
formed and 25 personnel were excluded because nephrectomy
had been performed for reasons other than trauma, most often
for nephrolithiasis. An additional four personnel were excluded
because renal disease was present prior to nephrectomy for
trauma. Finally, 43 personnel who underwent nephrectomy for
trauma were excluded as having suffered additional complica-
tions of battlefield injury which might also cause renal disease.
These complications included bladder dysfunction due to spinal
cord or nerve injury in 13 cases, osteomyelitis in nine cases,
chronic urinary tract infection in 13 cases, and other conditions
in eight cases. The remaining 62 subjects made up the study
population. In most cases, nephrectomy was the result of injury
caused by shrapnel or gunfire. Many sutjects also suffered
penetrating wounds of the chest, lacerations of the liver and
intestines, and bone fractures: these injuries were not grounds
for exclusion from the study.
Follow-up studies on the 62 subjects were carried out be-
tween July 1989 and June 1990. Twenty-eight patients were
found to have died. In most cases, death was recorded in
BIRLS files but in three cases death was discovered only when
we attempted to contact a subject recorded as living. Extensive
efforts were made to obtain medical histories of the subjects
who had died. Death certificates were obtained in most cases,
and records requested from physicians and hospitals recorded
as having treated the subjects. Surviving relatives provided the
names of additional physicians and hospitals in many cases.
Records obtained from all sources were reviewed for evidence
of kidney disease. Sections of kidney tissue were requested
when autopsy examinations had been performed.
Two subjects were recorded as living but could not be
located. The remaining 32 living subjects were contacted and
invited to participate in this study. Four subjects declined to
participate. Two of these said they did not suffer from kidney
disease and two provided no medical information. The 28
subjects who agreed to participate were referred to local
physicians who obtained medical histories and performed phys-
ical examinations. Urinalyses and measurements of serum urea
nitrogen and creatinine concentrations and protein and creati-
nine excretion rates in 24-hour urine collections were per-
formed by commercial or hospital laboratories selected by the
examining physicians.
Values for mean glomerular volume in autopsy sections of
kidney tissue were determined by a standard method [12]. The
extent of glomerular sclerosis was determined by examining all
glomerular profiles on a single section and expressing the
number showing global sclerosis as a percent of the number
examined. Control measurements were made on kidney sec-
tions from subjects with two kidneys who had autopsy exami-
nations at Willord Hall USAF Medical Center (San Antonio,
Texas, USA). Each study subject was matched with a control
subject who was within six years of the same age at the time of
death. The effect of uninephrectomy on survival was analyzed
using the Mantel-Cox test. Survival of the study subjects was
compared with survival of a group of Army enlisted men who
bought National Life Insurance policies during their WWII
military service [13]. For each subject in the study group, 10
subjects with similar birth years were included in the control
group. Data from NHANES II [14] were obtained on computer
tape and analyzed to provide control values for the prevalence
of hypertension and the serum creatinine concentration in US
males of age similar to the living study subjects. NHANES
subjects aged 65 to 74 years were compared with living study
subjects aged 65 to 81 years. Subjects in both groups were
considered hypertensive if they had a systolic blood pressure 
140 mm Hg, or a diastolic blood pressure  90 mm Hg, or were
taking any antihypertensive medication. Values are presented
as mean SD throughout.
Results
Survival
The study subjects, who were all male, underwent uninephre-
ctomy between August 1943 and September 1945. The majority
of the subjects were of European ancestry, while one subject
was of African ancestry, and at least one subject was of Latin
American ancestry. Average age at the time of nephretomy
was 25 4 years (range 19 to 37 years). Survival in the study
subjects and in an age-matched group of WWII US Army
enlisted men is depicted in Figure 1. Uninephrectomy did not
reduce survival in the study group.
Medical histories of the deceased subjects
Twenty-eight subjects died at an average age of 62 11 years
and an average interval after nephrectomy of 36 8 years. The
cause of death could be ascertained for 26 of these subjects. In
13 subjects death was due to cardiovascular disease, including
myocardial infarction (6), stroke (3), arrhythmia (2), and con-
gestive heart failure (2). In the remaining subjects death was
due to malignancy (5), accident (2), pulmonary embolism (1,
with Alzheimer's disease), hepatic cirrhosis (1), endocarditis
(1), subdural hematoma (1), and chronic obstructive pulmonary
disease (1). Death was attributed to renal failure in only one
case, as described below, and there was no record of any
subject having been on dialysis.
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Fig. 1. Survival among study subjects (broken line) and US Army
Veterans of WWII matched for age at the tune of military service (solid
line).
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Table 1. Evidence that remnant kidney function was abnormal in six deceased subjects
Subject Age at death
Years after
nephrectomy Cause of death
Record of kidney function
prior to deatha Other medical history
DI
D2
65
78
39
39
Uremia
Stroke
3 yrs
2 yrs
4 yrs
14 mo
Uprotein negative
[cre] 1.3 mg/dl
[crc] 1.8 mg/dl
BUN 20 mg/dl
BUN 104 mgldl
[cre 5.8 mg/dl
4 yrs
2 yrs
1 yr
6 yrs
14 mo
type 2 diabetes
myocardial infarction, CABG
bladder outlet obstruction, TURP
bilateral femoral-popliteal bypass
myocardial infarction
prostate carcinoma with bladder
outlet obstruction requiring
nephrostomy
D3 62 39 Malignancy 10 yrs
I mo
Uprotein 2+ to 4+
[crel 1.3 mg/dl
13 yrs
6 yrs
type 2 diabetes, myocardial infarction
abdominal aortic aneurysm repair
D4 62 33 COPD 4 yrs
4 mo
Uprotein 2+ to 4+
[crc] 1.2 mg/dl
? yrs
30 yrs
type 2 diabetes
passage of renal calculus
D5 56 30 Malignancy 9 yrs
3 mo
Uprotejn 480 mg/day
[crc] 1.1 mg/dl
24 yrs pyelonephritis
D6 56 35 Myocardial infarction 9 mo Uprotein 2,85 g/day
[cre] 0.9 mg/dl
Ccre 90 ml/min
9 mo
1 mo
myocardial infarction, congestive
heart failure
myocardial infarction, cardiac arrest
urinary tract infection
Abbreviations are: Uprojejo, urinary protein; CABG, coronary artery bypass graft; TURF, transurethral prostatectomy; COPD, chronic
obstructive pulmonary disease; [cre], serum creatinine concentration; Cere, creatinine clearance; ? yrs, unknown duration.
a The time denotes the number of years or months prior to death
The condition of the remnant kidney in the 28 deceased
subjects was ascertained from autopsy records and from reports
of urinalyses and serum creatinine determinations performed
within two years prior to death. Evidence that the remnant
kidney remained free of injury was found in 17 cases. Autopsy
reports were available in 11 cases. Chronic renal disease was
not noted on microscopic examination of kidney tissue in any of
these cases. Absence of renal injury was confirmed by review of
kidney sections obtained by the authors in nine cases. In five
cases in which autopsies were performed, reports of serum
creatinine levels of < 1.5 mg/dl within two years prior to death
provided additional evidence that remnant kidney function was
well preserved. Serum creatinine levels were also reported to
be < 1.5 mg/dl within two years prior to death in six subjects
who did not have autopsies. Urinalyses showing negative or
trace urine protein provided additional evidence that the rem-
nant kidney remained uninjured in nine of the 17 subjects who
had autopsies and/or serum creatinine levels < 1.5 mgldl within
two years prior to death.
Evidence of abnormal remnant kidney function was found in
six cases, as summarized in Table 1. In each of these cases
potential causes of kidney disease other than prior nephrectomy
could be identified. Death was attributed to renal failure in only
one subject (Table 1, Subject Dl). This subject developed renal
failure in association with type 2 diabetes, diffuse atheroscle-
rotic vascular disease, and congestive heart failure. Three years
prior to death and 36 years after nephrectomy, the serum
creatinine level was 1.3 mgldl and the urine was free of protein.
These findings suggest that progressive sclerosis of remnant
glomeruli did not cause renal failure in Subject Dl. Renal failure
in Subject D2 was clearly attributable to obstruction of the
bladder outlet by prostatic carcinoma. Proteinuria was reported
in two subjects with type 2 diabetes (D3 and D4). In both these
subjects, however, serum creatinine values were <1.5 mg/dl
during terminal hospital admissions more than 30 years after
nephrectomy. Two other subjects developed proteinuria but not
renal failure. One subject (D5) had a history of pyelonephritis in
the remnant kidney. Medical problems in the other subject (D6)
included hypertension, coronary artery disease, and urinary
tract infection.
Neither autopsy records nor reports of serum creatinine
determinations and urinalyses from within two years prior to
death could be obtained for five of the 28 deceased subjects.
There was evidence, however, that renal function remained
normal for more than 30 years after nephrectomy in two of
these subjects. One subject, who died following a myocardial
infarction 44 years after nephrectomy, had a serum creatinine of
1.1 mg/dl and a normal urinalysis 35 years after nephrectomy.
Another subject, who died following a cardiac arrest 36 years
after nephrectomy, had a serum creatinine of 0.7 mg/dl and a
normal urinalysis 33 years after nephrectomy.
Kidney function in the living subjects
Results obtained in 28 living subjects are summarized in
Table 2. Subjects were examined at an avbrage age of 69 4
years and an average interval after nephrectomy of 45 1
years. None of the subjects had serious renal insufficiency. The
highest serum creatinine value observed was 1.9 mg/dl. The
average serum creatinine value of 1.3 0.2 mgldl was similar to
the average serum creatinine value of 1.2 0.3 mg/dl observed
in men aged 65 to 74 in the NHANES II study [14]. The average
creatinine clearance observed in the current study was 75 29
ml/min and the average urine protein excretion rate was 146
152 mg/day. Nineteen of the 28 subjects were considered to be
hypertensive. The prevalence of hypertension in the study
subjects (68%) was thus not greater than the prevalence of
hypertension among men of similar age in the NHANES study
(59%). Moreover, hypertension among the study subjects was
in most cases not severe. Seven subjects were classified as
hypertensive only because the systolic blood pressure equaled
or exceeded 140 mm Hg or because they had a history of
hypertension though their blood pressure was not elevated at
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Table 2. Kidney function in the living subjects
All subjects
examined
N=28
Subjects considered
free of renal injury
N=23
Age at examination 69 (65—Si) 68 (65—77)
Years after nephrectomy 45 (44—47) 45 (44-47)
BUN mg/dl 17 (9—30) 16 (9—25)
Serum creatinine mg/dl 1.3 (0.9—1.9) 1.3 (0.9—1.5)
Creatinine clearance 75 (37—168) 77 (37—168)
mi/mm
Urinary protein mg/day 146 (<6—535) 90 (<6—242)
Blood pressure mm Hg 137/78 (92—180/48—92) 136/79 (93—180/63—92)
# Hypertensive 19/28 15/23
# Diabetic 8/28 4/23
Values are expressed
parentheses.
as mean values with range of values in
examination. Of the ii subjects receiving antihypertensive
medications, seven were receiving a single agent.
The remnant kidney was considered to be well preserved in
23 living subjects with serum creatinine values less than or
equal to 1.5 mg!dl and urine protein excretion rates less than 250
mg/day (Table 2). In these 23 subjects the average serum
creatinine level was 1.3 0.2 mg/dl and the average urine
protein excretion rate was 90 65 mg/day. Evidence of
abnormal remnant kidney function, as defined by a serum
creatinine level greater than 1.5 mg/dl or a protein excretion
rate greater than 250 mg/day, was found in five living subjects
(Table 3). Among these five subjects, four had type 2 diabetes
and four had a history of hypertension. None of these subjects
had severe hypertension, however, and none was taking any
antihypertensive medication at the time of examination.
Kidney structure
Kidney sections were obtained from autopsies performed in
nine of the deceased subjects and one of the living subjects who
died shortly after being examined for this study. Morphologic
findings in these ten subjects are summarized in Table 4.
Kidney weight was increased significantly in the study subjects
as compared with control subjects matched for age at the time
of death. Significant increases in glomerular volume and in the
prevalence of global glomerular sclerosis were not observed.
Discussion
Currently transplantation is more successful when kidneys
are obtained from living-related donors than when kidneys are
obtained from cadavers. In addition, the supply of cadaveric
kidneys is not adequate to meet the demand for transplantation.
The shortage of kidneys has prompted increased interest in
living nonrelated donation, which affords results similar to
those obtained with cadaveric kidneys [1, 2]. It seems likely,
moreover, that induction of donor-specific immune tolerance in
recipients will initially be achieved using donors selected prior
to transplantation. Demand for living kidney donation may thus
increase in the future.
The aim of this study was to confirm the safety of living
kidney donation. Because uninephrectomy for kidney donation
is a relatively new procedure, we examined the consequences
of uninephrectomy in Army personnel who lost a kidney due to
trauma during WWII. Results showed that nephrectomy had
few, if any, adverse consequences after 45 years. Mortality was
no different in nephrectomized subjects and age-matched con-
trols. Autopsy examinations, when performed, revealed no
increase in the prevalence of glomerulosclerosis. End-stage
renal failure was not observed, and cases of impaired renal
function could be attributed to causes other than prior nephrec-
tomy.
Previous studies have examined the effects of nephrectomy at
earlier intervals following kidney donation [5—11, 15—17]. Short-
term studies have shown that glomerular filtration rate and renal
blood flow increase by 40 to 60% within a few weeks following
nephrectomy [15—17]. These changes in kidney function are not
accompanied by increases in protein excretion rate or blood
pressure [18]. Longer-term studies have suggested that mainte-
nance of remnant kidney hyperfiltration and hypertrophy are
not associated with adverse effects over 10 to 20 years after
kidney donation [5—li]. In particular, few cases of renal insuf-
ficiency not attributable to causes other than nephrectomy have
been identified among transplant donors [7, 19—21]. Previous
studies have not extended over a sufficient period, however, to
afford complete reassurance to individuals contemplating kid-
ney donation early in adult life. Moreover, changes which could
reflect early kidney injury have been observed in some fol-
low-up studies of transplant donors. Thus, a modest increase in
average protein excretion has been observed in some but not all
groups of donors studied at 10 to 20 years after nephrectomy
[5—11, 22]. The current study suggests that this increase in
protein excretion is generally not an early sign of progressive
remnant glomerular injury. This result is consistent with the
finding that increased protein excretion does not invariably
reflect increased albumin excretion in kidney donors [5, 22].
Modest increases in average blood pressure and the incidence
of hypertension have also been observed in some studies of
transplant donors [6, 8]. The current study suggests that an
increase in blood pressure at 10 to 20 years after nephrectomy,
if it occurs, is not an early sign of the development of severe
hypertension in the donor population.
It should be emphasized that the current study assessed the
consequences of surgical nephrectomy in adults without prior
kidney disease. Patients with a solitary kidney due to unilateral
renal agenesis or to removal of a diseased kidney may develop
more serious renal injury. The largest study of unilateral renal
agenesis, based on the results of 232 autopsies, found that most
patients with this disorder live more than 40 years and that
death is not caused by renal disease in most cases [23]. In 36 of
the 232 patients studied, however, death was caused by failure
of the solitary kidney. Subsequent studies have provided more
detailed descriptions of renal failure due to focal glomerular
sclerosis in patients with unilateral agenesis [24, 25]. The
presence of reduced nephron number very early in life could
contribute to the development of focal sclerosis in these pa-
tients. Remnant kidney hyperfiltration and hypertrophy are
more pronounced when nephron number is reduced in infancy
than when nephron number is reduced later in life [261. These
potentially maladaptive changes could promote remnant gb-
merular disease in patients with unilateral renal agenesis. Per-
haps more importantly, malformations of the solitary kidney
and ureter frequently accompany unilateral renal agenesis [231.
The increased risk of kidney failure in patients with renal
agenesis may be the result of these anomalies rather than a
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Table 3. Evidence that remnant kidney function was abnormal in five living subjects
Serum
Subject
Age at
examination
creatinine
mg/dl
BUN Creatinine clearance
mi/mm
Urinary protein
ing/day
Blood pressure
mm Hg Other medical history
Al 81 1.8 30 54 377 92/48 Type 2 diabetes
A2 66 1.4 20 68 483 150/90 Type 2 diabetes
Hypertension
Atherosclerotic vascular disease
A3 69 1.9 27 54 535 129/71 Type 2 diabetes
Hypertension
Atherosclerotic vascular disease
A4 67 0.9 18 119 512 166/83 Hypertension
Atherosclerotic vascular disease
Prostatic hypertrophy, prostatitis
A5 73 1.7 20 37 172 146/73 Type 2 diabetes
Hypertension
Prostatic hypertrophy, TURP
Urinary tract infection
Abbreviation is TURP, transurethral prostatectomy.
Table 4. Kidney structure at autopsy
Study subjectsN=10 Control subjectsN=lO
Age at death 57 13 58 15
Years after nephrectomy 37 12 —
Kidney weight g 288 83 191 22V 3.7 1.2 3.2 0.8
% Sclerosis 2.1 1.7 1.7 1,8
Abbreviations are: V0. glomerular volume; % sclerosis, prevalence
of global glomerular sclerosis.
Kidney weight in controls was calculated as the mean weight of their
two kidneys.
a P < 0.05 vs. control
simple consequence of the uninephric state. The same consid-
erations apply to patients who undergo nephrectomy for Wilms'
tumor, most of whom are under four years of age at operation.
Recent studies suggest that the majority of these patients
exhibit no renal disease over 10 to 30 years after nephrectomy,
but development of focal sclerosis manifested by heavy pro-
teinuria has been observed in several cases [27—30]. Again,
however, nephrectomy may impose greater risks when per-
formed in young children than when performed in adults.
Moreover, the contralateral kidney in patients with Wilms'
tumor, like the solitary kidney in patients with unilateral
agenesis, is often abnormal [31, 32]. Late development of focal
sclerosis in patients with Wilms' tumor thus cannot be attrib-
uted solely to removal of half of a normal nephron population.
Abnormalities of the remnant kidney present at the time of
nephrectomy may also contribute to loss of kidney function in
the minority of patients who develop renal failure following
removal of a kidney for stone disease, hydronephrosis, or
tuberculosis [33—35].
It should also be emphasized that the current results are
applicable only to uninephrectomy. Recent studies have docu-
mented progressive glomerular injury in some, though not all,
patients subjected to removal of more than 50% of the renal
mass [4, 36]. These findings suggest that extensive renal abla-
tion causes more renal injury than uninephrectomy in humans
as well as in rats [3]. Uninephrectomy may be relatively benign
because it causes less remnant nephron hyperfunction and
hypertrophy than extensive renal ablation. Uninephrectomy
may also be relatively benign because it causes little increase in
systemic or glomerular capillary pressure. Rats subjected to
uninephrectomy, which have normal values for systemic and
glomerular pressure, develop less glomerular sclerosis than rats
subjected to bilateral segmental renal infarction, which have
high values for systemic and glomerular pressure though they
retain more than half of their renal mass [12].
Finally, the current study has a number of limitations even in
its application to uninephrectomy in healthy adults. Follow-up
was not complete, and kidney disease could have developed in
the few subjects who were not located or were unwilling to
participate. The authors feel this is unlikely, especially since
diagnosis of kidney disease would have entitled these subjects
to disability support. Limited sample size, however, might have
caused the authors to miss a small but significant risk of
progressive renal disease following nephrectomy. In particular,
limited sample size made it impossible to determine whether
nephrectomy increased the severity of renal injury initiated by
other disease processes, such as diabetes mellitus. The compo-
sition of the study population may also limit the applicability of
the current results. The subjects were all men. There is reason
to presume, however, that nephrectomy is as safe in women as
in men, since experimental studies suggest that males are at
least as susceptible as females to kidney injury following
nephron loss [3, 37]. A potentially more important weakness is
that the majority of the subjects were of European ancestry.
Susceptibility to hypertensive and diabetic kidney disease ap-
pears to be greater among Americans of African or Latin
American ancestry [38—41]. Presumably, these groups might
also exhibit an increased incidence of renal disease following
nephrectomy. Lastly, our subjects were injured soldiers and not
first degree relatives of patients with renal failure. The risk of
renal failure may be increased among the relatives of such
patients; indeed, several of the reported cases of renal failure
among transplant donors have been ascribed to hereditary
susceptibility to renal disease [20, 21]. Thus, while the current
study suggests that uninephrectomy in young adults has few
adverse consequences over 45 years, it still seems prudent to
recommend periodic follow-up of transplant donors.
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